These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9774461)

  • 1. Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate.
    Janciauskiene S; Rubin H; Lukacs CM; Wright HT
    J Biol Chem; 1998 Oct; 273(43):28360-4. PubMed ID: 9774461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin.
    Janciauskiene S; Eriksson S; Wright HT
    Nat Struct Biol; 1996 Aug; 3(8):668-71. PubMed ID: 8756322
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells.
    Sun YX; Wright HT; Janciauskiene S
    J Neurosci Res; 2002 Feb; 67(4):511-22. PubMed ID: 11835318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembly of N-terminal Alzheimer's β-amyloid and its inhibition.
    Prasanna G; Jing P
    Biochem Biophys Res Commun; 2021 Jan; 534():950-956. PubMed ID: 33143872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
    Hojati S; Ghahghaei A; Lagzian M
    J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
    Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
    Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.
    Janciauskiene S; Krakau T
    Doc Ophthalmol; 2003 May; 106(3):215-23. PubMed ID: 12737497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease.
    Janciauskiene S; Wright HT
    Bioessays; 1998 Dec; 20(12):1039-46. PubMed ID: 10048303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.
    Blanchard BJ; Chen A; Rozeboom LM; Stafford KA; Weigele P; Ingram VM
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14326-32. PubMed ID: 15388848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for self-propagation of different amyloid-β fibril conformations.
    Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
    Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma cell activation by Alzheimer's peptide Abeta1-42, alpha1-antichymotrypsin, and their mixture.
    Sun YX; Wright HT; Janciauskiene S
    Cell Mol Life Sci; 2002 Oct; 59(10):1734-43. PubMed ID: 12475184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistological study on the distribution of alpha 1-antichymotrypsin in Alzheimer's brain, compared to beta-amyloid precursor protein and beta-amyloid protein.
    Takahashi H; Hirokawa K; Tsukagoshi H
    J Neurol Sci; 1990 Nov; 99(2-3):301-10. PubMed ID: 2128319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 1-antichymotrypsin.
    Kalsheker NA
    Int J Biochem Cell Biol; 1996 Sep; 28(9):961-4. PubMed ID: 8930118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.
    Abraham CR; Potter H
    Ann Med; 1989; 21(2):77-81. PubMed ID: 2669847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic specificity of the reactive site loop of alpha1-antitrypsin, alpha1-antichymotrypsin, antithrombin III, and protease nexin I.
    Djie MZ; Stone SR; Le Bonniec BF
    J Biol Chem; 1997 Jun; 272(26):16268-73. PubMed ID: 9195929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer amyloid beta-protein.
    Nelson RB; Siman R; Iqbal MA; Potter H
    J Neurochem; 1993 Aug; 61(2):567-77. PubMed ID: 8336143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.
    Du Y; Bales KR; Dodel RC; Liu X; Glinn MA; Horn JW; Little SP; Paul SM
    J Neurochem; 1998 Mar; 70(3):1182-8. PubMed ID: 9489740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.
    Ng J; Kaur H; Collier T; Chang K; Brooks AES; Allison JR; Brimble MA; Hickey A; Birch NP
    J Biol Chem; 2019 May; 294(22):8806-8818. PubMed ID: 30996005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.